The global distribution and burden of dengue
By Samir Bhatt, Peter W. Gething, Oliver J. Brady, J. Messina, A. Farlow, C. Moyes, John M. Drake, J. Brownstein, A. Hoen, O. Sankoh and 8 more. Nature, 2013
3,652 citations recorded by the source corpus.
Dengue is a systemic viral infection transmitted between humans by Aedes mosquitoes. For some patients, dengue is a life-threatening illness. There are currently no licensed vaccines or specific therapeutics, and substantial vector control efforts have not stopped its rapid emergence and global spread. The contemporary worldwide distribution of the risk of dengue virus infection and its public health burden are poorly known. Here we undertake an exhaustive assembly of known records of dengue occurrence worldwide, and use a formal modelling framework to map the global distribution of dengue risk. We then pair the resulting risk map with detailed longitudinal information from dengue cohort studies and population surfaces to infer the public health burden of dengue in 2010. We predict dengue to be ubiquitous throughout the tropics, with local spatial variations in risk influenced strongly by rainfall, temperature and the degree of urbanization. Using cartographic approaches, we estimate there to be 390 million (95% credible interval 284–528) dengue infections per year, of which 96 million (67–136) manifest apparently (any level of disease severity). This infection total is more than three times the dengue burden estimate of the World Health Organization. Stratification of our estimates by country allows comparison with national dengue reporting, after taking into account the probability of an apparent infection being formally reported. The most notable differences are discussed. These new risk maps and infection estimates provide novel insights into the global, regional and national public health burden imposed by dengue. We anticipate that they will provide a starting point for a wider discussion about the global impact of this disease and will help to guide improvements in disease control strategies using vaccine, drug and vector control methods, and in their economic evaluation.
Subfields: Modeling and Simulation, Public Health, Environmental and Occupational Health
View Paper: https://www.semanticscholar.org/paper/16d70f3196b0528d79d1628cc90c09f31a92d398
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Public Health, Environmental and Occupational Health
- L. Petersen
- Eng Eong Ooi
- Annelies Wilder-Smith
- Jenny G. H. Low
- Po Ying Chia
- Sadie J. Ryan
- N. Murray
- M. Quam
Citations in the corpus
- Modified mRNA vaccines protect against Zika virus infection (2017, neutral): “This phenomenon could be relevant to ZIKV vaccination because DENV and ZIKV are related closely, and vaccinated subjects in or travelers to endemic areas could become exposed secondarily to DENV, which infects ~390 million people per year (Bhatt et al., 2013).”
- Vital Signs: Trends in Reported Vectorborne Disease Cases — United States and Territories, 2004–2016 (2018, positive): “Dengue viruses are estimated to infect nearly 400 million persons worldwide each year (1), and malaria (2) is a major cause of pediatric mortality in equatorial Africa.”
- Epidemiology of dengue: past, present and future prospects (2013, positive): “These data suggested 390 million dengue infections occur annually worldwide, including both apparent and inapparent infections, almost double the highest figure regularly reported to date.(43) Despite the level of uncertainty on total numbers, we have evidence today that every WHO region now has den”
- Detecting the impact of temperature on transmission of Zika, dengue, and chikungunya using mechanistic models (2017, positive): “Dengue virus (DENV) distribution and intensity in the Americas has increased over the last three decades, infecting an estimated 390 million people (96 million clinical) per year [2].”
- Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. (2013, positive): “West Nile virus (WNV) has re-emerged as an important cause of encephalitis in the United States and Europe, and there has been increasing recognition of dengue (the most common arboviral infection worldwide) and chikun-gunya viruses as causes of neurological complications [70 – 74].”
- The global distribution of the arbovirus vectors Aedes aegypti and Ae. albopictus (2015, positive): “DENV, with a nearly ubiquitous distribution in the tropics and more recently introduced to Europe (ECDC, 2014; Schaffner and Mathis, 2014), is the most prevalent human arboviral infection causing 100 million apparent annual infections world-wide with almost half of the world’s population at risk of ”